Machine learning assisted design of highly active peptides for drug discovery.

The discovery of peptides possessing high biological activity is very challenging due to the enormous diversity for which only a minority have the desired properties. To lower cost and reduce the time to obtain promising peptides, machine learning approaches can greatly assist in the process and eve...

Full description

Bibliographic Details
Main Authors: Sébastien Giguère, François Laviolette, Mario Marchand, Denise Tremblay, Sylvain Moineau, Xinxia Liang, Éric Biron, Jacques Corbeil
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-04-01
Series:PLoS Computational Biology
Online Access:https://doi.org/10.1371/journal.pcbi.1004074
id doaj-7c5302b911904fddab24e0081a11b3a3
record_format Article
spelling doaj-7c5302b911904fddab24e0081a11b3a32021-04-21T15:00:46ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582015-04-01114e100407410.1371/journal.pcbi.1004074Machine learning assisted design of highly active peptides for drug discovery.Sébastien GiguèreFrançois LavioletteMario MarchandDenise TremblaySylvain MoineauXinxia LiangÉric BironJacques CorbeilThe discovery of peptides possessing high biological activity is very challenging due to the enormous diversity for which only a minority have the desired properties. To lower cost and reduce the time to obtain promising peptides, machine learning approaches can greatly assist in the process and even partly replace expensive laboratory experiments by learning a predictor with existing data or with a smaller amount of data generation. Unfortunately, once the model is learned, selecting peptides having the greatest predicted bioactivity often requires a prohibitive amount of computational time. For this combinatorial problem, heuristics and stochastic optimization methods are not guaranteed to find adequate solutions. We focused on recent advances in kernel methods and machine learning to learn a predictive model with proven success. For this type of model, we propose an efficient algorithm based on graph theory, that is guaranteed to find the peptides for which the model predicts maximal bioactivity. We also present a second algorithm capable of sorting the peptides of maximal bioactivity. Extensive analyses demonstrate how these algorithms can be part of an iterative combinatorial chemistry procedure to speed up the discovery and the validation of peptide leads. Moreover, the proposed approach does not require the use of known ligands for the target protein since it can leverage recent multi-target machine learning predictors where ligands for similar targets can serve as initial training data. Finally, we validated the proposed approach in vitro with the discovery of new cationic antimicrobial peptides. Source code freely available at http://graal.ift.ulaval.ca/peptide-design/.https://doi.org/10.1371/journal.pcbi.1004074
collection DOAJ
language English
format Article
sources DOAJ
author Sébastien Giguère
François Laviolette
Mario Marchand
Denise Tremblay
Sylvain Moineau
Xinxia Liang
Éric Biron
Jacques Corbeil
spellingShingle Sébastien Giguère
François Laviolette
Mario Marchand
Denise Tremblay
Sylvain Moineau
Xinxia Liang
Éric Biron
Jacques Corbeil
Machine learning assisted design of highly active peptides for drug discovery.
PLoS Computational Biology
author_facet Sébastien Giguère
François Laviolette
Mario Marchand
Denise Tremblay
Sylvain Moineau
Xinxia Liang
Éric Biron
Jacques Corbeil
author_sort Sébastien Giguère
title Machine learning assisted design of highly active peptides for drug discovery.
title_short Machine learning assisted design of highly active peptides for drug discovery.
title_full Machine learning assisted design of highly active peptides for drug discovery.
title_fullStr Machine learning assisted design of highly active peptides for drug discovery.
title_full_unstemmed Machine learning assisted design of highly active peptides for drug discovery.
title_sort machine learning assisted design of highly active peptides for drug discovery.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2015-04-01
description The discovery of peptides possessing high biological activity is very challenging due to the enormous diversity for which only a minority have the desired properties. To lower cost and reduce the time to obtain promising peptides, machine learning approaches can greatly assist in the process and even partly replace expensive laboratory experiments by learning a predictor with existing data or with a smaller amount of data generation. Unfortunately, once the model is learned, selecting peptides having the greatest predicted bioactivity often requires a prohibitive amount of computational time. For this combinatorial problem, heuristics and stochastic optimization methods are not guaranteed to find adequate solutions. We focused on recent advances in kernel methods and machine learning to learn a predictive model with proven success. For this type of model, we propose an efficient algorithm based on graph theory, that is guaranteed to find the peptides for which the model predicts maximal bioactivity. We also present a second algorithm capable of sorting the peptides of maximal bioactivity. Extensive analyses demonstrate how these algorithms can be part of an iterative combinatorial chemistry procedure to speed up the discovery and the validation of peptide leads. Moreover, the proposed approach does not require the use of known ligands for the target protein since it can leverage recent multi-target machine learning predictors where ligands for similar targets can serve as initial training data. Finally, we validated the proposed approach in vitro with the discovery of new cationic antimicrobial peptides. Source code freely available at http://graal.ift.ulaval.ca/peptide-design/.
url https://doi.org/10.1371/journal.pcbi.1004074
work_keys_str_mv AT sebastiengiguere machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT francoislaviolette machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT mariomarchand machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT denisetremblay machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT sylvainmoineau machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT xinxialiang machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT ericbiron machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
AT jacquescorbeil machinelearningassisteddesignofhighlyactivepeptidesfordrugdiscovery
_version_ 1714668045733986304